Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response

被引:19
作者
Soboll, G
Nelson, KM
Leuthner, ES
Clark, RJ
Drape, R
Macklin, MD
Swain, WF
Olsen, CW
Lunn, DP
机构
[1] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA
[2] PowderJect Vaccines Inc, Madison, WI 53711 USA
关键词
equine influenza virus; DNA vaccination; cholera toxin;
D O I
10.1016/S0264-410X(03)00161-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously demonstrated that equine influenza virus hemagglutinin (HA) DNA vaccination protects ponies from challenge infection, and induces protective IgGa and IgGb responses. However, this approach does not induce a nasal IgA response. The objective of this study was to examine the value of cholera toxin (CT) administration as an adjuvant for intranasal HA DNA vaccination, and to measure protection 3 months after DNA vaccination. After an immunogenic dose of CT was determined, ponies were immunized on two occasions by intranasal administration of HA DNA and cholera toxin, or HA DNA alone. Ponies in both groups received two additional HA DNA particle mediated vaccinations at skin and mucosal sites. Antibody responses, and protection from challenge infection 3 months after the last vaccination were studied and compared to an influenza virus naive control group. Ponies in both vaccination groups produced virus-specific IgG antibodies in serum following vaccination and showed clinical protection from challenge infection 3 months after the last vaccination. Co-administration of CT plus HA DNA vaccination induced a nasal IgA response. In addition, analysis of antibody titers in nasal secretions indicated local production of nasal IgGb, which was amplified by CT administration. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3081 / +
页数:13
相关论文
共 34 条
[1]   CHARACTERIZATION OF THE CIRCULATING T-CELL RESPONSE AFTER ORAL IMMUNIZATION OF HUMAN VOLUNTEERS WITH CHOLERA-TOXIN-B SUBUNIT [J].
CASTELLOBRANCO, LRR ;
GRIFFIN, GE ;
POULTON, TA ;
DOUGAN, G ;
LEWIS, DJM .
VACCINE, 1994, 12 (01) :65-72
[2]   Functional characterization of equine dendritic cells propagated ex vivo using recombinant human GM-CSF and recombinant equine IL-4 [J].
Hammond, SA ;
Horohov, D ;
Montelaro, RC .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1999, 71 (3-4) :197-214
[3]   DURATION OF CIRCULATING ANTIBODY AND IMMUNITY FOLLOWING INFECTION WITH EQUINE INFLUENZA-VIRUS [J].
HANNANT, D ;
MUMFORD, JA ;
JESSETT, DM .
VETERINARY RECORD, 1988, 122 (06) :125-128
[4]  
HANNANT D, 1999, P 8 INT C EQ INF DIS, P50
[5]   COMPARISON OF INTRANASAL INOCULATION OF INFLUENZA HA VACCINE COMBINED WITH CHOLERA TOXIN-B SUBUNIT WITH ORAL OR PARENTERAL VACCINATION [J].
HIRABAYASHI, Y ;
KURATA, H ;
FUNATO, H ;
NAGAMINE, T ;
AIZAWA, C ;
TAMURA, S ;
SHIMADA, K ;
KURATA, T .
VACCINE, 1990, 8 (03) :243-248
[6]  
HIRABAYASHI Y, 1992, IMMUNOLOGY, V75, P493
[7]  
HOLMGREN J, 1994, AM J TROP MED HYG, V50, P42
[8]   CHOLERA-TOXIN AND CHOLERA-B SUBUNIT AS ORAL MUCOSAL ADJUVANT AND ANTIGEN VECTOR SYSTEMS [J].
HOLMGREN, J ;
LYCKE, N ;
CZERKINSKY, C .
VACCINE, 1993, 11 (12) :1179-1184
[9]   CHOLERA-TOXIN ADJUVANT GREATLY PROMOTES ANTIGEN PRIMING OF T-CELLS [J].
HORNQUIST, E ;
LYCKE, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2136-2143
[10]   Protection against influenza virus infection in mice immunized administration of hemagglutinin-expressing DNAs with electroporation [J].
Kadowaki, S ;
Chen, Z ;
Asanuma, H ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 2000, 18 (25) :2779-2788